CRISPR/Cas9 in Chronic Lymphocytic Leukemia



Downloads per month over past year

Hernández Sánchez, María (2022) CRISPR/Cas9 in Chronic Lymphocytic Leukemia. Encyclopedia, 2 (2). pp. 928-936. ISSN 2673-8392

[thumbnail of encyclopedia-02-00061.pdf]
Creative Commons Attribution.


Official URL:


Genome-editing systems such as Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas9 technology have uncovered new opportunities to model diseases such as chronic lymphocytic leukemia. CRISPR/Cas9 is an important means of advancing functional studies of Chronic Lymphocytic Leukemia (CLL) through the incorporation, elimination and modification of somatic mutations in CLL models.

Item Type:Article
Uncontrolled Keywords:leukemia; CRISPR/Cas9; editing
Subjects:Medical sciences > Medicine > Oncology
Medical sciences > Biology > Genetics
Medical sciences > Pharmacy > Biochemistry
ID Code:74852
Deposited On:30 Sep 2022 12:13
Last Modified:03 Oct 2022 06:58

Origin of downloads

Repository Staff Only: item control page